Close Menu

UCSF

The seven-year grant renews funding for the Antibacterial Resistance Leadership Group, led by Duke University and UCSF, with $15 million in 2020.

In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.

Using pilot data from the GenomeAsia 100K Consortium, researchers searched for long, diverged haplotypes indicative of admixture between modern and archaic humans.

A CFTR gene mutation found in 90 percent of US cystic fibrosis patients was only present in a third of Puerto Rican and 10 percent of Dominican patients.

Up And At 'Em

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

At ASHG, researchers showed why they're moving away from limited, linear human reference genome representations and towards a more inclusive future.

OncoCyte provided additional details about the history of the Razor test, its timeline for making it commercially available, and plans for a follow-on study.

For a Breakthrough

Winners of this year's Breakthrough Prize in the life sciences include researchers who studied neurodegenerative disorders and protein folding.

Just a Snooze Needed

Researchers uncovered a variant in the β1-adrenergic receptor gene that appears to influence how much sleep someone needs, the New York Times reports.

The $10 million initiative will include scientists from the University of California's campuses, as well as from governmental and nongovernmental organizations.

Pages

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.